Medical Technology

@xconomy.com 4 years ago

Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More

@xconomy.com 4 years ago

Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA

@xconomy.com 4 years ago

Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow

@xconomy.com 4 years ago

Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds

@xconomy.com 5 years ago

Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B

@xconomy.com 5 years ago

Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans

@xconomy.com 5 years ago

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs